Financial Year |
March 31 2023 |
Monetary Funds |
240,345,669.32 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
253,661,188.76 |
Advances to Suppliers |
11,734,303.53 |
Other Receivables |
3,409,607.07 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
217,900,914.74 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
8,735,559.92 |
Total Current Assets |
769,316,582.80 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
1,417,148.35 |
Fixed Assetes |
278,643,366.52 |
Under-construction Projects |
31,554,090.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
46,553,934.29 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
5,341,873.18 |
Other Non-Current Assets |
37,033,176.87 |
Sub-Total of Non-Current Assets |
403,288,325.61 |
Total Assets |
1,172,604,908.41 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
66,709,507.80 |
Accounts Payable |
67,383,539.32 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
21,425,818.02 |
Taxes Payable |
1,103,747.78 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,116,670.90 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
869,195.96 |
Other Current Liabilities |
213,110.81 |
Sub-Total of Current Liabilities |
168,373,802.16 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
4,094,067.58 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
11,303,202.24 |
Total Liabilities |
179,677,004.40 |
Paid-In Capital(Or Share Stock) |
183,750,000.00 |
Capital Surplus |
377,475,231.70 |
Surplus Reserve |
42,795,959.67 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
388,906,712.64 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
992,927,904.01 |
Owner's Equity(Stockholder's Equity) |
992,927,904.01 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,172,604,908.41 |